Boston Scientific Announces Results For Second Quarter 2018
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- Oracle results beat estimates, but shares fall on plans for $40 billion raise
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Alibaba falls on China AI capex report; Citi says selloff is premature
Boston Scientific (BSX) Tops Q2 EPS by 7c; Issues Solid Outlook
July 25, 2018 6:32 AM EDTBoston Scientific (NYSE: BSX) reported Q2 EPS of $0.41, $0.07 better than the analyst estimate of $0.34. Revenue for the quarter came in at $2.49 billion versus the consensus estimate of $2.47 billion.
GUIDANCE:
Boston Scientific sees Q3 2018 EPS of $0.33-$0.35, versus the consensus... More
